Cloning and chromosomal mapping of the murine norepinephrine transporter

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2241-2251

  Fritz, Jeffery D ^a   Jayanthi, Lankupalle D ^a   Thoreson, Molly A ^a   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Chromosome 11; Gene; Noradrenaline; Restriction fragment length variations; Transport

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CHROMOSOME 11; CHROMOSOME MAP; DEPRESSION; GENE ISOLATION; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; NEUROTRANSMITTER RELEASE; NORADRENALIN RELEASE; PRIORITY JOURNAL;

MURINAE; RODENTIA;

EID: 0031778096     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062241.x     Document Type: Article

References (66)

1. Apparsundaram S., Moore K. R., Hartzell H. C., and Blakely R. D. (1997) Molecular cloning and characterization of an epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana. J. Neurosci. 17, 2691-2702.
2. Axelrod J. and Kopin I. J. (1969) The uptake, storage, release, and metabolism of noradrenaline in sympathetic nerves. Prog. Brain Res. 31, 21-32.
3. Bannerjee S. P., Sharma V. K., and Khanna J. M. (1978) Alterations in beta-adrenergic receptor binding during ethanol withdrawal. Nature 276, 407-409.
4. Barker E. L. and Blakely R. D. (1995) Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs, in Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 321-333. Raven Press, New York.
5. Barker E. L. and Blakely R. D. (1996) Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol. Pharmacol. 50, 957-965.
6. Barker E. L., Kimmel H. L., and Blakely R. D. (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol. Pharmacol. 46, 799-807.
7. Blakely R. D., Clark J. A., Rudnick G., and Amara S. G. (1991) Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. Anal. Biochem. 194, 302-308.
8. Borowsky B. and Hoffman B. J. (1995) Neurotransmitter transporters: molecular biology, function, and regulation. Int. Rev. Neurobiol. 38, 139-199.
9. Brüss M., Kunz J., Lingen B., and Bönisch H. (1993) Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum. Genet. 91, 278-280.
10. Brüss M., Hammermann R., Brimijoin S., and Bönisch H. (1995) Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J. Biol. Chem. 270, 9197-9201.
11. Bucher P. (1990) Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212, 563-578.
12. Buck K. J. and Amara S. G. (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 91, 12584-12588.
13. Chenchik A., Diachenko L., Moqadam F., Tarabykin V., Lukyanov S., and Siebert P. D. (1996) Full-length cDNA cloning and determination of mRNA 5′ and 3′ ends by amplification of adaptor-ligated cDNA. Biotechniques 21, 526-534.
14. Crabbe J. C., Phillips T. J., Feller D. J., Hen R., Wenger C. D., Lessov C. N., and Schafer G. L. (1994) Genetic models of alcohol and drug abuse. Science 264, 1715-1723.
15. Crabbe J. C., Phillips T. J., Feller D. J., Hen R., Wenger C. D., Lessov C. N., and Schafer G. L. (1996) Elevated alcohol consumption in null mutant mice lacking 5HT1B serotonin receptors. Nat. Genet. 14, 98-101.
16. Cubells J. F., Kim K. S., Baker H., Volpe B. T., Chung Y., Houpt T. A., Wessel T. C., and Joh T. H. (1995) Differential in vivo regulation of mRNA encoding the norepinephrine transporter and tyrosine hydroxylase in rat adrenal medulla and locus ceruleus. J. Neurochem. 65, 502-509.
17. Devor E. J. and Cloninger C. R. (1989) Genetics of alcoholism. Annu. Rev. Genet. 23, 19-36.
18. Figlewicz D. P., Bentson K., and Ocrant I. (1993) The effect of insulin on norepinephrine uptake by PC12 cells. Brain Res. Bull. 32, 425-431.
19. Fletcher C. F., Lutz C. M., O'Sullivan T. N., Shaughnessey J. D. Jr., Hawkes R., Frankel W. N., Copeland N. G., and Jenkins N. A. (1996) Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87, 607-617.
20. French S. W., Palmer D. S., Narod M. E., Reid P. E., and Ramsey S. W. (1975) Noradrenergic sensitivity of the cerebral cortex after chronic ethanol ingestion and withdrawal. J. Pharmacol. Exp. Ther. 194, 319-326.
21. Ganguly P. K., Dhalla K. S., Innes I. R., Beamish R. E., and Dhall N. S. (1986) Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ. Res. 59, 684-693.
22. Giros B., El Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., and Caron M. G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-390.
23. Giros B., Wang Y. M., Suter S., McLeskey S. B., Pifl C., and Caron M. G. (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985-15988.
24. Giros B., Jaber M., Jones S. R., Wightman R. M., and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
25. Goldstein D. S., Lenders J. W. M., Kaler S. G., and Eisenhofer G. (1996) Catecholamine phenotyping: clues to diagnosis, treatment, and pathophysiology of neurogenetic disorders. J. Neurochem. 67, 1781-1790.
26. Heils A Teufel A., Petri S., Seemann M., Bengel D., Balling U., Riederer P., and Lesch K. P. (1995) Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J. Neural Transm. 102, 247-254.
27. Howerton T. C. (1982) Norepinephrine, gamma-aminobutyric acid and choline reuptake kinetics and the effects of ethanol in long-sleep and short-sleep mice. Subst. Alcohol Act. 3, 89-99.
28. Israel Y., Carmichael F. J., and Macdonald J. A. (1973) Effects of ethanol on norepinephrine uptake and electrically stimulated release in brain tissue. Ann. NY Acad. Sci. 215, 38-48.
29. Iversen L. L. (1978) Uptake processes for biogenic amines, in Handbook of Psychopharmacology (Iversen I., ed), pp. 381-442. Plenum Press, New York.
30. Jursky F., Tamura S., Mandiyan S., Nelson H., and Nelson N. (1994) Structure, function, and brain localization of neurotransmitter transporters. J. Exp. Biol. 196, 283-295.
31. Kaye D. M., Wiviott S. D., Kobzik L., Kelly R. A., and Smith T. W. (1997) S-Nitrosothiols inhibit neuronal norepinephrine transport. Am. J. Physiol. 272, H875-H883.
32. Kumer S. C. and Vrana K. E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443-462.
33. Lee F. J. S., Pristupa Z. B., Ciliax B. J., Levey A. I., and Niznik H. B. (1996) The dopamine transporter carboxyl-terminal tail. J. Biol. Chem. 271, 20885-20894.
34. Levitt P. and Noebels J. L. (1981) Mutant mouse tottering: selective increase of locus ceruleus axons in a defined single-locus mutation. Proc. Natl. Acad. Sci. USA 78, 4630-4634.
35. Lin A. M. Y., Bickford P. C., Palmer M. R., and Gerhardt G. A. (1993) Ethanol inhibits the uptake of exogenous norepinephrine from the extracellular space of the rat cerebellum. Neurosci. Lett. 164, 71-75.
36. Lingen B., Brüss M., and Bönisch H. (1994) Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter. FEBS Lett. 342, 235-238.
37. Lorang D., Amara S. G., and Simerly R. B. (1993) Cell-type specific expression of catecholamine transporters in the rat brain. J. Neurosci. 14, 4903-4914.
38. Lu D., Yu K., Paddy M. R., Rowland N. E., and Raizada M. K. (1996) Regulation of norepinephrine transport system by angiotensin II in neuronal cultures of normotensive and spontaneously hypertensive rat brains. Endocrinology 137, 763-772.
39. Markel P. D., Bennett B., Beeson M., Gordon L., Simpson V. J., and Johnson T. E. (1996) Strain distribution patterns for genetic markers in the LSXSS recombinant inbred series. Mamm. Genome 7, 408-412.
40. Markel P. D., Bennett B., Beeson M., Gordon L., and Johnson T. E. (1997) Confirmation of quantitative trait loci for ethanol sensitivity in long-sleep and short-sleep mice. Genome Res. 7, 92-99.
41. Melikian H. E., McDonald J. K., Gu H., Rudnick G., Moore K. R., and Blakely R. D. (1994) Human norepinephrine transporter: biosynthetic studies using a site-directed polyclonal antibody. J. Biol. Chem. 269, 12290-12297.
42. Meredith I. T., Eisenhofer G., Lambert G. W., Dewar E. M., Jennings G. L., and Esler M. D. (1993) Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88, 136-145.
43. Noebels J. L. and Sidman R. L. (1979) Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 204, 1334-1336.
44. Oda S. I. (1981) A new allele of the tottering locus, rolling mouse Nagoya, on chromosome 8 in the mouse. Jpn. J. Genet. 56, 295-299.
45. Pacholczyk T. (1992) Expression cloning of a human norepinephrine transporter. Ph.D. thesis, Yale University School of Medicine, New Haven.
46. Pacholczyk T., Blakely R. D., and Amara S. G. (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354.
47. Pörzgen P., Bönisch H., and Brüss M. (1995) Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem. Biophys. Res. Commun. 215, 1145-1150.
48. Rabin R. A., Wolfe B. B., Dibner M. D., Zahniser N. R., Melchior C., and Molinoff P. B. (1980) Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J. Pharmacol. Exp. Ther. 213, 491-496.
49. Ramamoorthy J. D., Ramamoorthy S., Leibach F. H., and Ganapathy V. (1995) Human placental monoamine transporters as targets for amphetamines. Am. J. Obstet. Gynecol. 173, 1782-1787.
50. Ramamoorthy S., Prasad P. D., Kulanthaivel P., Leibach F. H., Blakely R. D., and Ganapathy V. (1993) Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. Biochemistry 32, 1346-1353.
51. Rauch U., Grimpe B., Kulbe G., Arnold-Ammer L., Beier D. R., and Fassler R. (1995) Structure and chromosomal localization of the mouse neurocan gene. Genomics 28, 405-410.
52. 3H)glutamate. Life Sci. 12, 433-441.
53. Rowe L. B., Nadeau J. H., Turner R., Frankel W. N., Letts V. A., Eppig J. T., Ko M. S. H., Turston S. J., and Birkenmeier E. H. (1994) Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm. Genome 5, 253-274.
54. Saito T., Lee J. M., Hoffman P. L., and Tabakoff B. (1987) Effects of chronic ethanol treatment on the β-adrenergic receptor-coupled adenylate cyclase system of mouse cerebral cortex. J. Neurochem. 48, 1817-1822.
55. Sambrook J., Fritsch E. F., and Maniatis T., eds (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
56. Seyfarth M., Richardt G., Mizsnyak A., Kurz T., and Shomig A. (1996) Transient ischemia reduces norepinephrine release during sustained ischemia. Neural preconditioning in isolated rat heart. Circ. Res. 78, 573-580.
57. Shafqat S., Velaz-Faircloth M., Guadano-Ferraz A., and Fremeau R. T. (1993) Molecular characterization of neurotransmitter transporters. Mol. Endocrinol. 7, 1517-1529.
58. Shimada S., Kitayama S., Lin C., Patel A., Nanthakumar E., Gregor P., Kuhar M., and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-577.
59. Sumners C. and Raizada M. K. (1986) Angiotensin II stimulates norepinephrine uptake in hypothalamus-brain stem neuronal cultures. Am. J. Physiol. 250, C236-C244.
60. Thomas S. A., Matsumoto A. M., and Palmiter R. D. (1995) Noradrenaline is essential for mouse fetal development. Nature 374, 643-646.
61. Tsuji S. and Meier H. (1971) Evidence for allelism of leaner and tottering in the mouse. Genet. Res. 17, 83-88.
62. Usdin T. B., Mezey E., Chen C., Brownstein M. J., and Hoffman B. J. (1991) Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. USA 88, 11168-11171.
63. Vatta M. S., Bianciotti L. G., and Fernandez B. E. (1993) Influence of atrial natriuretic factor on uptake, intracellular distribution, and release of norepinephrine in rat adrenal medulla. Can. J. Physiol. Pharmacol. 71, 195-200.
64. Wakade A. R., Wakade T. D., Poosch M., and Bannon M. J. (1996) Noradrenaline transport and transporter mRNA of rat chromaffin cells are controlled by dexamethasone and nerve growth factor. J. Physiol. (Lond.) 494, 67-75.
65. Yang H., Lu D., Yu K., and Raizada M. K. (1996) Regulation of neuromodulatory actions of angiotensin II in the brain neurons by the ras-dependent mitogen-activated protein kinase pathway. J. Neurosci. 16, 4047-4058.
66. Zhou Q.-Y., Qualfe C. J., and Palmiter R. D. (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374, 640-643.